Package contents: 3 ampoules 3ml
[DOI] [PubMed] [Google Scholar] 161.Katare R.G., Caporali A., Oikawa A., Meloni M., Emanueli C., Madeddu P
But all these are meant to give only temporary results
Example 1: Athlete annual plan Off-season (Months 1-4) : Build Ipamorelin + CJC-1295 full protocol BPC-157 for injury prevention Focus: Maximum muscle/strength gains Cost : $800-1,200 Pre-season (Months 5-6) : Transition Reduce GH peptides to 3x weekly Continue BPC-157 Focus: Maintain gains, prepare for competition Cost : $300-500 In-season (Months 7-10) : Perform BPC-157 only (recovery + injury prevention) Add TB-500 if minor injuries occur Focus: Recovery, injury management Cost : $400-800 Post-season (Months 11-12) : Recover BPC-157 + TB-500 stack for any accumulated damage Rest from GH peptides Focus: Healing, reset Cost : $300-600 Annual cost : $1,800-3,100 Adjustments : Add peptides as needed for specific issues Example 2: Weight loss to body recomposition Phase 1 (Months 1-5) : Major weight loss Semaglutide full protocol 30-40 lbs weight loss Cost : $650-1,100 Phase 2 (Months 6-7) : Transition Taper semaglutide to maintenance Start Ipamorelin for muscle preservation Increase calories gradually Cost : $400-650 Phase 3 (Months 8-12) : Muscle building Ipamorelin + CJC-1295 full protocol Calorie surplus, progressive training 8-12 lbs muscle gain Cost : $1,000-1,600 Annual cost : $2,050-3,350 Results : 30-40 lbs fat lost, 8-12 lbs muscle gained, completely transformed body composition Example 3: Comprehensive longevity protocol All 12 months continuous : Ipamorelin + CJC-1295 (GH optimization) NAD+ peptides (mitochondrial support) GHK-Cu (skin + inflammation) BPC-157 added as needed for any issues Monthly cost : $500-800 Annual cost : $6,000-9,600 Expected results : Optimal aging markers, maintained vitality, excellent recovery, sustained energy Blood work schedule : Every 3 months Adjustments : Reduce/increase individual peptides based on results and blood work Use our peptide cost calculator for exact budgeting
QA/RA managers need to take standard steps when tracking the risk of pancreatitis and evaluating thyroid C-cell tumors (based on data from rodents)
